Analysis of Drug Permeation Mechanism across Oral Mucosa Using Cultured Stratified Cell Layers
使用培养的分层细胞层分析药物在口腔粘膜的渗透机制
基本信息
- 批准号:15590131
- 负责人:
- 金额:$ 2.37万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2003
- 资助国家:日本
- 起止时间:2003 至 2004
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
In order to clarify the drug permeation mechanism across oral mucosa, the optimal culture condition for the stratified cell layer using HaCaT cells was determined and the various basic studies were performed on glucose transport systems.As to the culture condition for HaCaT cells, DMEM EGF(+) or DMEM+Supplement EGF(+) was selected from the point of proliferative activity. From histological view point, DMEM EGF(+) was selected. From the transmucosal electrical resistance, DMEM : Ham's F-12 EGF(+) was the best. Taking factors such as cell viability, stratification, transmucosal electrical resistance and glucose transport into consideration, the best condition for HaCaT cell layers was selected to be the culture for 3 to 4 weeks using DMEM EGF(+).The result of glucose transport experiments using HaCaT cells showed that the uptake of D-glucose into cells was much faster than that of L-glucose, suggesting that the expression of stereo-selective glucose transporters in HaCaT cells. Western blot analysis showed that the presence of SGLT, GLUTs 1,2 and 3. Nevertheless, the transport rate of D-glucose across the cell layer was not significantly different from that of L-glucose. The reason for this observation is remaining unsolved.As the passively transported drugs, mannitol, melatonin and estradiol were selected, and the Papp values were measured. The results of Papp values for the three drugs were correlated with their lipophilicity, suggesting that the cultured HaCaT cell layers are effective for the evaluation of the oral-mucosal permeability to passively transported drugs.
为了阐明口服粘膜的药物渗透机制,确定了使用HACAT细胞进行分层细胞层的最佳培养条件,并在葡萄糖传输系统上进行了各种基本研究。作为HACAT细胞的培养条件,DMEM EGF(+)或DMEM+DMEM+补充EGF(+)从垂体的点中选择。从组织学角度来看,选择了DMEM EGF(+)。从透射电阻中,DMEM:HAM的F-12 EGF(+)是最好的。 Taking factors such as cell viability, stratification, transmucosal electrical resistance and glucose transport into consideration, the best condition for HaCaT cell layers was selected to be the culture for 3 to 4 weeks using DMEM EGF(+).The result of glucose transport experiments using HaCaT cells showed that the uptake of D-glucose into cells was much faster than that of L-glucose, suggesting that the expression of stereo-selective glucose HACAT细胞中的转运蛋白。蛋白质印迹分析表明,SGLT,GLUT 1,2和3的存在。然而,跨细胞层的D-葡萄糖的转运速率与L-葡萄糖的转运率没有显着差异。该观察结果的原因仍未解决。选择被动运输的药物,甘露醇,褪黑激素和雌二醇,并测量了PAPP值。这三种药物的PAPP值的结果与它们的亲脂性相关,这表明培养的HACAT细胞层有效评估口腔粘膜渗透性对被动运输的药物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KIMURA Toshikiro其他文献
KIMURA Toshikiro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KIMURA Toshikiro', 18)}}的其他基金
Analysis of dissolution kinetics and first-pass elimination of orally administered drugs and its application to prediction of absorption behavior after oral administration
口服药物溶出动力学和首过消除分析及其在预测口服后吸收行为中的应用
- 批准号:
21590158 - 财政年份:2009
- 资助金额:
$ 2.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of first-pass effect in small intestinal mucosa and its application to prediction of drug absorption behavior after oral administration
小肠黏膜首过效应分析及其在预测口服药物吸收行为中的应用
- 批准号:
19590144 - 财政年份:2007
- 资助金额:
$ 2.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of physiological factors regulating oral absorption behaviors of drugs and its application to prediction of plasma concentration-time profile
药物口服吸收行为生理因素分析及其在血药浓度-时间曲线预测中的应用
- 批准号:
17590124 - 财政年份:2005
- 资助金额:
$ 2.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of Carrier-Mediated Transport Systems in Drug Absorption from Oral Mucosa
口腔粘膜药物吸收中载体介导的转运系统分析
- 批准号:
10672041 - 财政年份:1998
- 资助金额:
$ 2.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Experimental Analysis of Anomalous Pharmacokinetics in Disease State: Pharmacokinetics in Diabetes
疾病状态下异常药代动力学的实验分析:糖尿病的药代动力学
- 批准号:
63571097 - 财政年份:1988
- 资助金额:
$ 2.37万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似国自然基金
高光伏渗透率场景下农村住宅建筑负荷柔性量化评估与优化调度研究
- 批准号:52278104
- 批准年份:2022
- 资助金额:54.00 万元
- 项目类别:面上项目
高光伏渗透率场景下农村住宅建筑负荷柔性量化评估与优化调度研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
基于低渗透率众包轨迹数据的城市干道交通状态评估诊断与控制优化
- 批准号:61873018
- 批准年份:2018
- 资助金额:63.0 万元
- 项目类别:面上项目
中国电动汽车未来发展规模、综合效益和激励政策分析
- 批准号:71774095
- 批准年份:2017
- 资助金额:48.0 万元
- 项目类别:面上项目
井中雷达储层渗透率评价方法研究
- 批准号:41674138
- 批准年份:2016
- 资助金额:65.0 万元
- 项目类别:面上项目
相似海外基金
Phosphodiesterase 4B Inhibition as a Therapeutic Target for Alcohol-associated Liver Disease
磷酸二酯酶 4B 抑制作为酒精相关性肝病的治疗靶点
- 批准号:
10354185 - 财政年份:2023
- 资助金额:
$ 2.37万 - 项目类别:
Microbiome targeted oral butyrate therapy in Gulf War multisymptom illness
微生物组靶向口服丁酸盐治疗海湾战争多症状疾病
- 批准号:
10367805 - 财政年份:2023
- 资助金额:
$ 2.37万 - 项目类别:
Shifting paradigms to emerging toxins in freshwater cyanobacterial blooms
淡水蓝藻水华中新出现的毒素的范式转变
- 批准号:
10912318 - 财政年份:2023
- 资助金额:
$ 2.37万 - 项目类别:
Evaluating a novel, orally-active TREM2-targeting drug in AD
评估一种新型口服活性 TREM2 靶向药物治疗 AD 的效果
- 批准号:
10735206 - 财政年份:2023
- 资助金额:
$ 2.37万 - 项目类别:
Cerebrovascular mitochondria as mediators of neuroinflammation in Alzheimer's Disease
脑血管线粒体作为阿尔茨海默病神经炎症的介质
- 批准号:
10723580 - 财政年份:2023
- 资助金额:
$ 2.37万 - 项目类别: